Benign neoplasm of major salivary glands

CD2_BENIGN_SALIVARY

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D11
  • Cause of death: ICD-10 D11

2 out of 7 registries used, show all original rules.

3456

4. Check minimum number of events

None

3456

5. Include endpoints

3853

6. Filter based on genotype QC (FinnGen only)

3853

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10-D36
Name in latin
Neoplasmata benigna glandularum salivariarum majorum

Similar endpoints

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 24561 12823 11557
Only index persons 21875 11713 10162
Unadjusted period prevalence (%)
Whole population 0.35 0.37 0.32
Only index persons 0.41 0.43 0.39
Median age at first event (years)
Whole population 58.45 58.19 58.72
Only index persons 57.54 57.27 57.85

-FinnGen-

Key figures

All Female Male
Number of individuals 3853 1999 1854
Unadjusted period prevalence (%) 0.75 0.68 0.82
Median age at first event (years) 58.20 55.57 61.05

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3462
Matched controls
34622
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D11.70
ICD-10 Finland
Gland sublingual
3720.9
323.0
347
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
10.7
323.0
761
888
ELB40
NOMESCO Finland
Partial parotidectomy
1452.9
323.0
1497
18
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
4503599627370496.0
323.0
2700
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
13.4
301.3
552
483
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
188.0
252.0
261
15
2102A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Major salivary glands
+∞
226.6
215
*
21020
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Salivary gland
+∞
214.8
204
*
ELB30
NOMESCO Finland
Excision of submandibular gland
67.5
211.9
245
39
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
363.3
207.2
207
6
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
66.9
174.5
202
32
ELB50
NOMESCO Finland
Total parotidectomy
147.7
172.1
182
13
D11.9
ICD-10 Finland
Benign neoplasm: Major salivary gland, unspecified
705.8
138.8
136
*
4405
FHL
Partial removal of the parotid gland
151.2
137.4
145
10
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
35.0
130.0
170
51
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
118.6
1231
6219
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
14.7
115.5
199
143
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
125.3
112.8
121
10
K11.2
ICD-10 Finland
Sialoadenitis
7.1
101.4
262
396
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
23.8
100.9
146
64
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.6
70.5
216
406
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
16.0
67.9
112
72
ZXA05
NOMESCO Finland
Left side
1.9
54.8
1001
6042
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.9
54.6
186
394
ZXA00
NOMESCO Finland
Right side
1.9
50.5
1041
6521
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
28.9
50.1
68
24
D11.7
ICD-10 Finland
Benign neoplasm: Other major salivary glands
+∞
43.8
42
*
WX402
NOMESCO Finland
General anaesthesia
2.0
42.7
608
3293
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
7.3
41.5
102
143
K11.9
ICD-10 Finland
Disease of salivary gland, unspecified
14.4
39.9
68
48
4404
FHL
Complete removal of the parotid gland
391.8
39.1
39
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
12.0
39.0
72
61
EL3AT
NOMESCO Finland
Salivary gland biopsy with ultrasound guidance
74.4
39.0
44
6
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
16.9
37.6
60
36
ELB99
NOMESCO Finland
Other excision of salivary gland
361.0
36.0
36
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.6
35.8
274
1097
C07.71
ICD-10 Finland
Malignant tumor in the deep part of the parotid gland
181.8
34.8
36
*
J01DB01
ATC
cefalexin; oral
1.6
33.4
2684
23439
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
6.7
31.8
82
124
S04
ICPC
Lump/swelling localized
2.3
31.7
321
1484
8550/3-C07.9
ICD-O-3
Acinar cell carcinoma of parotid gland
315.6
30.9
31
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.1
30.2
97
194
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.9
26.5
89
187
WX110
NOMESCO Finland
Local anesthesy
1.5
26.3
2137
18063
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
7.4
25.9
62
85
DWD00
NOMESCO Finland
Reoperation for superficial heamorrhage in surgery of ear, nose and larynx
32.3
24.6
32
10
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.1
24.4
139
461
8430/3-C07.9
ICD-O-3
Mucoepidermoid carcinoma of parotid gland
+∞
24.0
23
*
S18
ICPC
Laceration/cut
1.5
23.7
1342
10454
N02BE01
ATC
paracetamol; systemic, rectal
1.6
23.6
2836
25714
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
22.0
718
4929
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
21.8
357
2004
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
20.1
198
904
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
73.9
19.7
22
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
16.5
19.6
31
19
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
21.7
19.5
28
13
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.3
18.1
55
105
K11.88
ICD-10 Finland
Other diseases of salivary glands
15.7
17.5
28
18
J01DA01
ATC
[U] cefalexin; systemic
1.4
17.4
1963
16951
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
11.1
17.2
32
29
R03BB04
ATC
tiotropium bromide; inhalant
1.7
17.1
341
2037
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
16.7
16
*
D11.71
ICD-10 Finland
Gland submandibular
+∞
16.7
16
*
C08.09
ICD-10 Finland
Malignant tumor of the submandibular or submaxillary gland, other or unspecified histology
90.5
16.6
18
*
TQA05
NOMESCO Finland
Puncture of skin of head or neck
27.7
16.5
22
8
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.9
16.0
65
168
C82.1
ICD-10 Finland
Follicular lymphoma grade II
6.2
15.9
42
68
C08.99
ICD-10 Finland
Malignant tumor of unspecified large salivary gland, other or unspecified histology
85.5
15.6
17
*
TPJ05
NOMESCO Finland
Needle biopsy of lymph node
38.2
15.4
19
5
B02
ICPC
Lymph gland(s) enlarged/painful
6.6
15.3
39
60
4403
FHL
Submandibular gland removal
14.0
15.0
25
18
K11.3
ICD-10 Finland
Abscess of salivary gland
18.4
14.7
22
12
TEL00
NOMESCO Finland
Needle biopsy of salivary gland
+∞
14.6
14
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
5.9
14.5
40
69
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.4
13.5
48
110
UDC00
NOMESCO Finland
Ear microscopy
1.8
13.5
221
1240
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.7
13.4
273
1642
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
13.3
327
2073
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
12.8
951
7570
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
7.2
12.7
30
42
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
12.5
12
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
12.5
12
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
5.0
12.4
39
79
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
12.4
1160
9550
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
6.9
12.4
30
44
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
12.3
595
4389
SPAT1153
SPAT
Removal of sutures
1.3
12.3
960
7690
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
12.3
716
5469
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
12.0
1149
9485
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.2
11.9
123
576
K11.5
ICD-10 Finland
Sialolithiasis
3.4
11.4
54
161
J01FF01
ATC
clindamycin; systemic
1.4
11.3
784
6153
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
12.7
11.1
19
15
ZXC99
NOMESCO Finland
Other special technic in surgery
12.7
11.1
19
15
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
12.7
11.1
19
15
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
5.6
11.0
31
56
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.1
10.9
117
560
EP1AE
SPAT
NA
3.5
10.8
48
137
K11.4
ICD-10 Finland
Fistula of salivary gland
60.2
10.6
12
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.4
10.6
37
85
A10BA02
ATC
metformin; oral
1.3
10.5
839
6718
4402
FHL
Removal or exploration of a salivary change (eg ranula)
+∞
10.4
10
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
10.4
187
1080
N02AX02
ATC
tramadol; systemic, rectal
1.3
10.3
1266
10748
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.9
10.3
145
773
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
7.1
10.3
24
34
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
10.1
1318
11274
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
3.1
10.0
54
178
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.9
10.0
138
730
ELW99
NOMESCO Finland
Other operation on salivary gland
26.1
9.8
13
5
Z72.0
ICD-10 Finland
Tobacco use
2.4
9.7
79
332
EWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of teeth, jaws, mouth and pharynx
13.4
9.7
16
12
C08.00
ICD-10 Finland
Malignant tumor of submandibular or submaxillary gland, not histology
55.1
9.6
11
*
A02BC02
ATC
pantoprazole; systemic
1.3
9.6
1977
17812
A07AA02
ATC
nystatin; oral
1.7
9.6
185
1093
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.1
9.6
50
162
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
9.5
100
477
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
9.5
297
1998
8070/3-C07.9
ICD-O-3
Squamous cell carcinoma, NOS, of parotid gland
+∞
9.4
9
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
3.1
9.1
49
162
C07
ICD-10 Finland
Malignant neoplasm of parotid gland
36.8
9.0
11
*
130
Kela drug reimbursment
Malignant tumour
1.6
9.0
238
1539
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.8
8.9
151
860
AAH50
NOMESCO Finland
Cranial nerve anastomosis
18.6
8.9
13
7
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.8
8.6
133
734
R02
ICPC
Shortness of breath/dyspnoea
1.5
8.6
321
2243
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
11.6
8.6
15
13
K11.1
ICD-10 Finland
Hypertrophy of salivary gland
16.3
8.5
13
8
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
8.5
588
4587
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
3.1
8.5
45
148
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
20.1
8.5
12
6
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.9
8.4
125
682
ELB70
NOMESCO Finland
Excision of parotid gland neoplasm or other lesion extending into parapharyngeal space
+∞
8.3
8
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
8.2
271
1844
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.7
8.2
158
937
ELA30
NOMESCO Finland
Biopsy of salivary gland
7.5
8.1
18
24
H02AB06
ATC
prednisolone; systemic
1.2
8.1
1367
11950
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.6
8.1
229
1506
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
6.8
8.1
19
28
UDQ22
NOMESCO Finland
Microlaryngoscopy
3.8
8.0
32
85
JN4BD
NOMESCO Finland
Extensive body CT
1.5
8.0
315
2228
C03CA01
ATC
furosemide; systemic
1.3
8.0
849
7029
R03AC02
ATC
salbutamol; inhalant
1.2
7.8
1486
13153
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
7.7
1161
10010
J01AA02
ATC
doxycycline; systemic
1.2
7.7
2421
22571
R61.0
ICD-10 Finland
Localized hyperhidrosis
6.4
7.7
19
30
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
7.7
1410
12420
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.6
1981
18092
K11
ICD-10 Finland
Diseases of salivary glands
11.9
7.6
13
11
PJA10
NOMESCO Finland
Exploration of lymph nodes
2.8
7.5
45
162
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
3.4
7.5
34
101
K11.0
ICD-10 Finland
Atrophy of salivary gland
80.3
7.4
8
*
8200/3-C07.9
ICD-O-3
Adenoid cystic carcinoma of parotid gland
80.3
7.4
8
*
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
13.4
7.4
12
9
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.3
996
8479
R4110
NOMESCO Finland
Physiotherapy
1.3
7.3
751
6180
8147/3-C07.9
ICD-O-3
Basal cell adenocarcinoma of parotid gland
+∞
7.3
7
*
C08.92
ICD-10 Finland
Coastal adenocarcinoma of unspecified salivary gland
+∞
7.3
7
*
4704
FHL
Neck tumor removal
9.4
7.3
14
15
QAA99
NOMESCO Finland
Other local destruction of skin of head or neck
5.8
7.2
19
33
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
7.3
7.2
16
22
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.4
7.1
58
248
8500/3-C07.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of parotid gland
30.1
7.1
9
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.3
7.1
33
100
T90
ICPC
Diabetes non-insulin dependent
1.3
7.1
657
5335
N07BA03
ATC
varenicline; oral
1.7
7.1
129
755
L28
ICPC
Limited function/disability (L)
1.4
7.1
434
3320
P01AB01
ATC
metronidazole; oral, rectal
1.2
7.0
1094
9446
XX3DW
NOMESCO Finland
Time consuming IT work
1.4
7.0
286
2036
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
7.0
1313
11563
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
7.0
559
4450
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.1
6.9
72
346
G51.0
ICD-10 Finland
Bell palsy
2.1
6.9
71
338
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
3.3
6.8
32
98
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
10.9
6.8
12
11
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
6.8
784
6544
XW1XT
NOMESCO Finland
Biopsy from other organ close to skin with other quidance
40.1
6.8
8
*
C08.02
ICD-10 Finland
Cystic adenocarcinoma of the submandibular or submaxillary glands
40.1
6.8
8
*
K11.70
ICD-10 Finland
Hypoptyalism
3.8
6.7
26
68
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
2.4
6.7
54
229
QAE30
NOMESCO Finland
Excision and repair of surgical scar in head or neck
7.2
6.7
15
21
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
6.7
690
5678
ZZK00
NOMESCO Finland
Graft of nerve
22.5
6.7
9
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
5.9
6.6
17
29
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
6.6
525
4177
8941/3-C07.9
ICD-O-3
Carcinoma ex pleomorphic adenoma of parotid gland
70.0
6.4
7
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.3
6.4
55
242
104
Kela drug reimbursment
Thyroid insufficiency
1.5
6.4
191
1276
DEB00
NOMESCO Finland
Cortical mastoidectomy
14.3
6.4
10
7
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.4
312
2298
N30.0
ICD-10 Finland
Acute cystitis
1.4
6.3
338
2529
N02AA05
ATC
oxycodone; systemic
1.3
6.3
394
3022
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
3.5
6.3
27
78
BAA60
NOMESCO Finland
Total thyroidectomy
2.1
6.3
67
326
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.3
612
5001
C08.91
ICD-10 Finland
Adenocarcinoma of mixed cell type in unspecified large salivary gland
+∞
6.2
6
*
8502/3-C07.9
ICD-O-3
Secretory carcinoma of parotid gland
+∞
6.2
6
*
8430/3-C08.0
ICD-O-3
Mucoepidermoid carcinoma of submandibular gland
+∞
6.2
6
*
D21.0
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of head, face and neck
4.3
6.2
21
49
H92.0
ICD-10 Finland
Otalgia
1.7
6.1
115
684
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
12.5
6.1
10
8
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
6.1
196
1333
R52.9
ICD-10 Finland
Pain, unspecified
1.5
6.0
207
1426
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.0
6.0
74
381

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
829
748
13.85
307.65
1.4
1.2
—
—
—
0
0
(4035726)
610
2880
2.33
71.41
1.5
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1769
12838
1.70
54.58
2.2
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
742
4201
1.95
52.64
1.3
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1861
14930
1.48
30.08
6.3
5.9
%
57.8
57.6
0.19
1722
13937
(3006315) Basophils [#/volume] in Blood
1944
15774
1.47
29.38
6.2
5.8
e9/l
0.0
0.0
0.27
1670
13602
(3019069) Monocytes/100 leukocytes in Blood
1842
14810
1.47
29.06
6.6
6.3
%
8.9
8.7
1.23
1705
13839
(3022096) Basophils/100 leukocytes in Blood
1790
14325
1.47
28.86
6.5
6.0
%
0.7
0.7
0.26
1658
13341
(3006504) Eosinophils/100 leukocytes in Blood
1831
14733
1.46
28.60
6.5
6.0
%
2.9
2.9
0.23
1689
13709
(3001604) Monocytes [#/volume] in Blood
1931
15697
1.46
28.60
6.2
5.7
e9/l
0.6
0.6
2.05
1655
13530
(3002030) Lymphocytes/100 leukocytes in Blood
1871
15153
1.46
28.04
6.6
6.1
%
27.0
27.3
0.58
1729
14074
(3013115) Eosinophils [#/volume] in Blood
1988
16306
1.45
27.74
6.5
6.0
e9/l
0.2
0.2
0.02
1731
14268
(3019198) Lymphocytes [#/volume] in Blood
1967
16115
1.45
27.53
6.3
5.8
e9/l
1.9
1.9
0.14
1725
14145
(3013650) Neutrophils [#/volume] in Blood by Automated count
2191
18323
1.45
27.46
9.7
8.9
e9/l
4.3
4.2
1.28
1925
15990
(3007853) Bacteria identified in Skin by Aerobe culture
580
3781
1.63
23.61
1.9
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1932
16353
1.36
19.38
7.8
6.9
mmol/l
1.2
1.2
0.20
1642
13759
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1788
15008
1.36
18.65
4.3
4.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
71
225
3.20
18.04
1.4
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2187
19065
1.34
17.10
5.9
4.8
mmol/l
6.9
6.8
1.43
2069
17912
(42870588) Differential panel, method unspecified - Blood
1336
10871
1.35
16.44
6.2
5.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1269
10245
1.36
16.44
2.6
2.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1752
14858
1.33
16.20
7.1
6.0
mmol/l
1.2
1.2
0.04
1601
13432
(3018095) Leukocytes [#/volume] in Urine
1386
11364
1.34
16.13
4.2
3.8
e6/l
90.1
103.0
0.17
981
8174
(3024561) Albumin [Mass/volume] in Serum or Plasma
1673
14158
1.32
15.44
5.2
4.9
g/l
35.1
35.2
0.31
1549
13148
(3018418) pH of Serum or Plasma
1202
9701
1.35
15.37
4.5
4.1
ph
7.4
7.4
1.48
226
1862
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2727
24747
1.35
15.25
8.7
7.7
u/l
80.0
79.1
0.34
2584
23308
(3024980) IgG subclass 4 [Mass/volume] in Serum
106
457
2.36
14.96
2.1
1.6
g/l
1.0
0.8
0.54
81
348
(40768795) Lymph node Pathology biopsy report
80
302
2.68
14.92
1.4
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
541
3823
1.48
14.88
4.0
4.2
u/l
238.0
245.0
0.57
514
3614
(3033658) Prothrombin time (PT) actual/Normal
1029
8160
1.36
14.62
4.7
4.0
%
88.1
88.8
0.36
1017
7953
(3030467) Casts [#/volume] in Urine by Automated count
1119
9001
1.34
14.44
3.5
3.2
e6/l
0.3
0.5
3.13
831
6832
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
57
182
3.16
14.37
6.2
6.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1207
9835
1.33
14.22
3.6
3.3
e6/l
42.3
101.2
2.27
914
7602
(3000492) Spirometry study
422
2861
1.53
14.13
1.6
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1626
13819
1.31
14.12
11.2
9.8
e9/l
0.0
0.0
0.73
1336
11316
(3042936) Bacteria identified in Isolate by Culture
632
4651
1.43
13.99
2.1
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1945
16947
1.30
13.93
6.9
6.3
umol/l
11.0
11.7
1.63
1873
16084
(3037467) Urinalysis macro (dipstick) panel - Urine
2427
21794
1.31
13.76
4.8
4.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1083
8722
1.34
13.73
3.4
3.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2340
20958
1.30
13.27
5.1
4.6
e6/l
3299.7
1827.3
0.24
40
305
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
683
5146
1.40
13.15
3.5
3.0
e6/l
2.3
2.2
0.04
379
2829
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
724
5520
1.38
12.97
3.2
2.8
e6/l
1.5
1.1
0.38
420
3181
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
70
270
2.62
12.57
5.4
4.7
u/ml
90.0
50.6
0.26
22
77
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3299
31175
1.40
12.01
18.7
15.2
mg/l
24.9
24.5
0.26
2753
25021
(3013707) Erythrocyte sedimentation rate by Westergren method
2563
23405
1.28
11.59
4.7
4.1
mm/h
13.6
12.8
1.62
2380
21607
(3015377) Calcium [Moles/volume] in Serum or Plasma
1309
11030
1.28
11.43
3.7
3.4
mmol/l
2.3
2.4
0.39
1150
9562
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3046
28490
1.33
11.33
5.3
4.8
mu/l
2.6
2.1
0.34
2785
25932
(3014576) Chloride [Moles/volume] in Serum or Plasma
561
4193
1.40
11.19
8.3
6.9
mmol/l
104.6
104.3
0.76
539
4096
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
970
7878
1.31
11.18
2.5
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
984
8032
1.30
10.88
7.4
6.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2580
23659
1.27
10.84
4.4
4.0
pmol/l
15.1
14.9
3.78
2327
21422
(40760892) CBC W Ordered Manual Differential panel - Blood
844
6750
1.32
10.82
4.9
4.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1557
13541
1.25
10.07
10.9
9.8
inr
1.3
1.3
0.46
453
3842
(3003458) Phosphate [Moles/volume] in Serum or Plasma
568
4333
1.36
9.93
5.7
5.8
mmol/l
1.0
1.0
0.98
522
4020
(3023368) Bacteria identified in Blood by Culture
1099
9189
1.27
9.90
4.9
4.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
69
302
2.31
9.55
1.3
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3122
29486
1.31
9.53
17.6
14.2
ml/min/173m2
78.8
78.5
0.34
2658
24472
(3044889) 12 lead EKG panel
2441
22430
1.24
9.14
4.3
3.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
678
5383
1.31
8.99
3.4
3.3
mmol/l
0.8
0.8
0.83
634
5010
(3002385) Erythrocyte distribution width [Ratio]
2737
25505
1.25
8.86
22.4
18.3
%
13.9
13.8
2.33
2686
24917
(3027135) IgG subclass 1 [Mass/volume] in Serum
64
285
2.27
8.55
1.6
1.4
g/l
7.2
6.9
0.19
45
199
(3024139) IgG subclass 3 [Mass/volume] in Serum
64
285
2.27
8.55
1.6
1.4
g/l
0.4
0.4
0.35
45
199
(3028192) IgG subclass 2 [Mass/volume] in Serum
64
285
2.27
8.55
1.6
1.4
g/l
2.7
2.9
0.49
45
197
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
748
6056
1.29
8.53
3.4
3.0
mmol/l
2.5
2.5
0.26
662
5317
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1482
12987
1.23
8.49
2.3
2.2
nmol/l
77.2
78.2
0.60
1324
11581
(3005719) IgG [Mass/volume] in Serum or Plasma
327
2337
1.44
8.36
2.9
2.7
g/l
10.7
10.6
0.23
297
2124
(3023103) Potassium [Moles/volume] in Serum or Plasma
3392
32561
1.35
8.17
21.3
17.7
mmol/l
4.0
4.0
0.71
3317
31691
(3019550) Sodium [Moles/volume] in Serum or Plasma
3384
32482
1.34
8.07
21.2
17.6
mmol/l
139.6
139.7
0.28
3316
31658
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
506
3911
1.34
8.05
9.1
7.3
kpa
5.2
5.1
1.45
481
3726
(3027801) Oxygen [Partial pressure] in Arterial blood
506
3911
1.34
8.05
9.1
7.3
kpa
12.3
12.2
0.17
481
3724
(3003396) Base excess in Arterial blood by calculation
504
3895
1.34
8.02
9.1
7.3
mmol/l
1.4
1.1
0.79
393
3041
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1523
13440
1.22
8.01
2.1
2.0
pmol/l
93.1
94.7
0.58
838
6977
(4062490)
63
287
2.21
7.99
1.6
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
258
1778
1.48
7.98
11.1
9.4
mmol/l
24.5
24.3
0.35
239
1664
(3026782) Osmolality of Urine
782
6422
1.27
7.91
3.0
2.8
mosm/kgh2o
548.0
548.5
0.02
656
5477
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
397
2971
1.37
7.78
2.6
2.4
u/l
36.4
53.9
0.55
342
2555
(3021601) Nitrite [Presence] in Urine by Test strip
1716
15361
1.21
7.71
5.6
5.0
estimate
0.0
0.0
0.50
318
2906
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1157
9962
1.23
7.66
2.3
2.2
u/l
185.7
233.0
1.30
1084
9318
(3020682) Albumin/Creatinine [Ratio] in Urine
1195
10343
1.23
7.49
4.2
4.0
mg/mmol
9.0
9.3
0.08
784
6530
(3000991) Gas panel - Venous blood
369
2751
1.38
7.40
9.9
8.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
828
6895
1.26
7.39
2.7
2.6
e6/l
4.7
5.3
1.06
705
6054
(3027945) Reticulocytes/100 erythrocytes in Blood
490
3815
1.33
7.39
2.6
2.5
%
1.8
1.8
0.38
429
3361
(3009261) Glucose [Presence] in Urine by Test strip
1730
15560
1.20
7.23
4.2
3.8
estimate
0.0
0.0
1.34
308
2810
(3035350) Ketones [Presence] in Urine by Test strip
1702
15333
1.20
6.86
4.1
3.7
estimate
0.0
0.0
0.00
311
2858
(3020779) Urea [Moles/volume] in Serum or Plasma
398
3049
1.34
6.70
7.9
7.3
mmol/l
10.1
10.3
0.21
377
2900
(3002032) Base excess in Venous blood by calculation
401
3077
1.34
6.68
3.8
3.6
mmol/l
2.1
2.0
0.27
324
2486
(3016502) Oxygen saturation in Arterial blood
449
3506
1.32
6.62
9.7
7.6
%
95.3
95.5
0.38
435
3373
(3009508) Creatinine [Moles/volume] in Urine
1169
10206
1.21
6.53
3.3
3.2
mmol/l
7.4
7.5
0.29
972
8538
(3021447) Carbon dioxide [Partial pressure] in Venous blood
401
3090
1.33
6.49
3.9
3.6
kpa
6.0
5.8
2.29
393
2993
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
444
3479
1.31
6.39
3.7
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1127
9822
1.21
6.38
3.3
3.3
mg/l
466.4
344.3
0.35
738
6206
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
196
1339
1.49
6.38
1.8
2.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
41
172
2.40
6.36
1.8
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
196
1341
1.49
6.33
1.8
2.4
g/l
7.5
7.4
0.12
139
1006
(3015736) pH of Urine
1342
11898
1.20
6.30
3.8
3.5
—
5.8
—
0
8
(3019977) pH of Arterial blood
42
179
2.36
6.29
1.6
2.7
ph
7.4
7.4
0.63
12
59
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
768
6446
1.24
6.29
4.2
3.8
ng/l
703.3
527.6
0.29
634
5182
(3028026) IgM [Mass/volume] in Serum or Plasma
256
1847
1.41
6.25
1.7
1.9
g/l
1.3
1.4
0.60
232
1676
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
195
1339
1.48
6.20
1.8
2.4
g/l
3.9
3.8
0.09
136
957
(3037522) Nuclear Ab [Titer] in Serum
505
4042
1.29
6.19
1.4
1.3
titre
663.2
523.5
0.76
124
857
(3025159) Blasts/100 leukocytes in Blood
326
2454
1.36
6.17
4.1
4.1
%
1.1
0.4
0.34
73
623
(3026008) Bacteria identified in Urine by Culture
1120
9792
1.20
6.08
3.8
3.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
158
1045
1.53
6.01
2.5
3.5
ratio
1.4
2.2
0.74
17
84
(3004588) Protein electrophoresis panel - Serum or Plasma
315
2370
1.36
5.98
1.9
2.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
330
2507
1.35
5.89
3.8
3.9
ng/l
92.0
93.3
0.09
277
2147
(3021440) Promyelocytes/100 leukocytes in Blood
342
2613
1.34
5.87
4.1
4.1
%
0.2
0.2
0.16
89
745
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
117
726
1.63
5.85
1.5
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
356
2746
1.33
5.73
4.1
4.1
%
1.3
0.9
1.36
96
803
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
250
1831
1.39
5.62
3.6
3.3
pmol/l
4.3
4.4
2.03
228
1603
(3045142) Bone marrow Pathology biopsy report
70
381
1.85
5.57
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
126
807
1.58
5.55
2.2
3.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1119
9857
1.19
5.49
3.2
3.1
ng/l
1683.6
1526.5
0.38
976
8465
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
159
1078
1.50
5.42
2.6
3.6
mg/l
34.5
66.2
1.56
127
876
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
25
89
2.82
5.40
1.0
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
159
1079
1.49
5.40
2.6
3.6
mg/l
64.3
111.9
0.42
126
875
(3004789) Transferrin [Mass/volume] in Serum or Plasma
576
4764
1.25
5.34
2.6
2.5
g/l
2.3
2.3
0.36
528
4409
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3420
33170
1.28
5.33
12.3
10.8
u/l
25.6
26.2
0.97
3305
31964
(3021879) Hepatitis B virus core Ab [Presence] in Serum
266
1987
1.36
5.31
1.3
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
467
3775
1.27
5.28
1.8
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
144
963
1.51
5.25
1.8
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
850
7330
1.20
5.23
3.9
3.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
395
3131
1.29
5.22
2.5
2.2
g/l
0.2
0.2
0.80
369
2911
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1154
10229
1.18
5.22
2.7
2.6
u/l
53.4
58.4
3.19
1075
9430
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1444
13038
1.17
5.21
3.0
2.8
ug/l
136.8
139.4
0.13
1320
11990
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
179
1254
1.45
5.19
1.9
2.4
g/l
3.1
3.1
0.04
139
982
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
77
442
1.76
5.18
1.3
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
373
2938
1.30
5.17
8.7
6.9
mmol/l
1.3
1.4
0.19
363
2833
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1151
10207
1.18
5.17
3.7
3.3
u/l
31.3
37.3
2.14
1098
9678
(3022948) Iron [Moles/volume] in Serum or Plasma
614
5132
1.23
5.16
2.6
2.5
umol/l
12.5
12.9
0.66
563
4759
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3416
33147
1.27
5.16
21.5
17.8
umol/l
79.6
79.2
0.23
3416
33134
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
653
5502
1.22
5.08
1.9
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
892
7749
1.20
5.05
1.6
1.6
nmol/l
20.4
20.5
0.05
769
6621
(40768797) Stomach Pathology biopsy report
542
4483
1.24
5.02
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
177
1248
1.44
4.97
1.8
2.4
g/l
10.0
10.3
0.33
153
1058
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
941
8227
1.19
4.95
2.3
2.2
mg/l
3.1
3.0
0.31
794
6999
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
44
213
2.08
4.93
2.8
2.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
261
1971
1.35
4.88
8.3
7.2
mmol/l
25.0
24.9
0.10
254
1959
(3052851) Hemolysis interference index of Serum or Plasma
143
971
1.49
4.87
3.4
3.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
403
3231
1.28
4.87
10.4
8.1
g/l
120.5
121.4
0.34
389
3112
(3007461) Platelets [#/volume] in Blood
3524
34364
1.30
4.85
26.8
22.3
e9/l
248.6
248.1
0.15
3434
33457
(3006184) Hemoglobin [Mass/volume] in Capillary blood
111
714
1.57
4.85
2.2
2.1
g/l
128.5
129.0
0.08
87
511
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
146
998
1.48
4.82
2.0
2.3
g/l
0.1
0.0
0.37
134
918
(3020630) Protein [Mass/volume] in Serum or Plasma
360
2851
1.29
4.80
2.1
2.7
g/l
66.3
66.3
0.05
331
2596
(3010813) Leukocytes [#/volume] in Blood
3525
34384
1.30
4.77
26.8
22.3
e9/l
7.0
6.8
3.73
3419
33360
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
25
96
2.61
4.72
1.6
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
25
96
2.61
4.72
1.6
2.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
3524
34379
1.29
4.72
26.8
22.3
e12/l
4.5
4.5
0.01
3415
33365
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
462
3780
1.25
4.71
1.7
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
661
5621
1.21
4.67
1.5
1.5
g/l
2.5
2.5
0.18
394
3410
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
23
85
2.72
4.67
1.0
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
3524
34386
1.29
4.65
27.0
22.4
g/l
134.6
134.9
0.39
3477
33851
(3024731) MCV [Entitic volume]
3523
34375
1.29
4.65
26.7
22.2
fl
91.4
91.3
0.53
3472
33837
(3024354) Oxygen [Partial pressure] in Venous blood
323
2533
1.30
4.64
3.4
2.9
kpa
4.6
4.6
0.08
315
2445
(40761511) CBC panel - Blood by Automated count
3329
32278
1.23
4.61
16.6
14.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
3522
34375
1.29
4.56
26.7
22.2
pg
30.4
30.4
0.12
3472
33833
(3026493) Urate [Moles/volume] in Serum or Plasma
975
8606
1.18
4.54
2.6
2.7
umol/l
6528.5
5387.9
0.27
839
7436
(3000494) Fungus identified in Specimen by Culture
460
3781
1.25
4.50
1.6
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
533
4455
1.23
4.47
2.8
2.6
%
21.0
22.8
2.74
462
3789
(46235355) HIV 1 and 2 tests - Meaningful Use set
512
4265
1.23
4.43
1.7
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
530
4435
1.23
4.39
1.4
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
796
6925
1.19
4.38
1.7
1.8
mg/l
1.5
1.3
0.92
611
5316
(3042111) Morphology [Interpretation] in Bone marrow Narrative
93
589
1.59
4.38
1.3
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
317
2501
1.29
4.37
3.9
3.9
%
1.2
0.6
1.30
65
577
(40767503) Oxygen content in Capillary blood by calculation
108
709
1.54
4.35
2.7
2.4
%
15.9
16.3
0.40
60
351
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
165
1179
1.42
4.35
2.2
2.3
ug/l
331.8
684.2
1.17
157
1112
(3018677) aPTT in Platelet poor plasma by Coagulation assay
598
5083
1.21
4.23
2.1
2.1
s
30.2
29.8
0.73
586
4928
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1385
12618
1.15
4.21
4.2
3.8
ng/l
39.7
90.4
0.81
981
8990
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3023
29117
1.18
4.15
6.8
6.0
mmol/mol
40.7
40.1
2.63
2781
26837
(3017143) Hepatitis C virus Ab [Presence] in Serum
380
3086
1.26
4.15
1.5
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
134
932
1.45
4.10
2.0
2.3
g/l
0.0
0.0
0.00
122
857
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
208
1564
1.35
4.05
3.6
3.8
mmol/l
24.4
24.1
0.55
186
1401
(3019060) Gas panel - Arterial blood
290
2287
1.29
4.03
5.5
4.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
147
1045
1.42
4.01
1.9
2.2
g/l
38.2
37.5
0.67
127
896
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
132
920
1.45
4.01
2.0
2.3
g/l
0.0
0.0
0.00
121
856
(3015171) Extractable nuclear Ab [Units/volume] in Serum
160
1156
1.40
3.99
1.5
1.2
u/ml
0.5
1.4
1.21
11
99
(3023520) Reticulocytes [#/volume] in Blood
356
2885
1.26
3.96
2.6
2.5
e9/l
73.9
69.7
1.09
274
2211
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
157
1145
1.39
3.73
1.9
2.5
g/l
0.6
1.0
1.34
136
992
(3009542) Hematocrit [Volume Fraction] of Blood
2896
27875
1.16
3.70
20.1
16.2
%
39.5
39.5
0.09
2035
19179
(3003338) MCHC [Mass/volume]
2692
25792
1.15
3.62
24.1
19.5
g/l
331.6
332.1
2.36
2668
25579
(3022217) INR in Platelet poor plasma by Coagulation assay
530
4525
1.20
3.58
25.6
25.6
inr
1.3
1.4
0.32
81
632
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
435
3645
1.22
3.57
1.5
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1909
17908
1.13
3.53
2.8
2.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
183
1385
1.34
3.46
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
176
1326
1.34
3.43
1.9
1.8
u/l
39.4
38.9
0.12
150
1158
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
599
5189
1.18
3.43
1.3
1.3
iu/ml
50.1
35.3
0.76
211
1634
(3002619) Bacteria identified in Specimen by Culture
16
58
2.77
3.42
1.3
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
40
216
1.86
3.40
2.1
2.1
%
14.7
13.7
0.20
20
88
(3000012) Reticulocyte production index
34
174
1.96
3.38
1.4
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
48
276
1.75
3.33
1.1
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
357
2962
1.23
3.24
2.6
2.4
ug/l
5.8
7.3
1.31
315
2584
(3011412) CD3 cells [#/volume] in Blood
49
286
1.72
3.24
2.0
2.1
e9/l
1.1
1.1
0.25
32
175
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
36
192
1.88
3.19
1.7
2.1
e6/l
487.0
540.3
0.26
29
163
(3037756) Immunofixation for Serum or Plasma
103
719
1.44
3.18
1.6
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
156
1169
1.35
3.18
3.2
3.0
u/ml
0.4
0.3
0.12
73
665
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
115
820
1.41
3.16
3.4
2.9
mg/l
1.6
1.6
0.17
102
747
(3036481) Cortisol [Moles/volume] in Serum or Plasma
345
2865
1.22
3.12
2.4
2.2
nmol/l
380.1
371.0
0.32
314
2616
(4010399)
278
2256
1.25
3.11
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
244
1951
1.27
3.09
1.6
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
29
145
2.01
3.09
1.6
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
8
7.51
3.05
1.5
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
16
62
2.59
3.04
1.9
2.0
e6/l
111.1
162.5
—
9
28
(3042631) Mycobacterium sp identified in Specimen
71
464
1.54
3.03
2.5
2.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
139
1033
1.36
3.00
5.3
4.1
mmol/l
3.9
3.9
0.17
117
968
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
328
2723
1.22
2.98
4.5
3.8
mmol/l
1.2
1.2
4.14
294
2372
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
431
3677
1.19
2.95
3.3
2.7
umol/l
8.5
8.8
0.11
376
3206
(3021901) Oxygen saturation in Capillary blood
89
615
1.46
2.92
3.4
2.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
105
750
1.41
2.89
3.6
3.7
—
—
—
0
0
(3004451) EKG impression Narrative
31
164
1.90
2.85
1.1
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
416
3551
1.19
2.84
3.8
4.0
ug/l
28.1
23.7
0.10
359
2900
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1277
11808
1.12
2.83
4.5
4.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2118
20142
1.11
2.83
3.5
3.2
u/l
55.2
51.7
0.77
1969
18617
(3030981) Hyaline casts [#/volume] in Urine by Automated count
217
1733
1.27
2.81
3.3
2.8
e6/l
0.2
0.3
1.37
209
1688
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
31
165
1.89
2.80
1.6
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
31
165
1.89
2.80
1.6
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
419
3588
1.19
2.76
1.3
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
151
1153
1.32
2.75
3.3
2.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
349
2943
1.20
2.72
2.6
2.9
ng/l
237.0
210.1
0.50
303
2682
(3009445) Proteinase 3 Ab [Units/volume] in Serum
172
1340
1.30
2.72
1.5
1.5
—
19.2
—
0
35
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
33
182
1.82
2.69
1.7
2.1
e9/l
0.2
0.2
0.19
28
161
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
48
295
1.64
2.68
1.4
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
58
374
1.56
2.66
1.4
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
291
2419
1.22
2.64
1.7
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
101
730
1.39
2.63
1.6
1.9
iu/l
3.6
4.5
0.41
33
255
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
29
155
1.88
2.61
1.6
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
66
441
1.51
2.59
2.7
2.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
110
809
1.37
2.58
1.8
1.9
mg/l
10.3
11.7
1.16
102
737
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
192
1529
1.27
2.57
2.7
2.5
%
0.7
0.7
0.25
182
1461
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
47
291
1.62
2.56
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
62
411
1.52
2.53
2.4
2.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
19
89
2.14
2.44
1.2
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
899
8207
1.12
2.44
3.9
3.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
52
335
1.56
2.43
3.6
3.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
101
742
1.37
2.41
4.0
3.1
mmol/l
1.7
1.6
0.38
101
718
(3026389) Candida sp identified in Specimen by Organism specific culture
62
416
1.50
2.41
1.2
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
115
863
1.34
2.40
3.8
3.2
mmol/l
24.9
24.9
0.01
108
750
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
177
1410
1.27
2.38
5.9
5.3
%
1.9
1.6
1.32
169
1318
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
8
6.26
2.37
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
82
586
1.41
2.32
1.3
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
104
775
1.35
2.29
4.3
4.5
kpa
8.3
8.5
0.42
97
764
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
88
641
1.38
2.24
1.7
1.8
nmol/l
1.0
0.8
0.86
73
529
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
47
303
1.56
2.21
2.2
2.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
103
771
1.35
2.21
4.2
4.5
mmol/l
2.7
2.6
0.05
75
538
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
100
746
1.35
2.20
1.4
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
103
772
1.34
2.20
4.3
4.5
kpa
5.1
5.0
0.42
96
762
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
110
833
1.33
2.19
1.3
1.3
—
14.1
—
0
18
(3005322) IgE [Units/volume] in Serum or Plasma
219
1807
1.22
2.18
1.5
1.3
u/ml
314.4
210.2
0.99
201
1660
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
24
3.34
2.18
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
28
158
1.78
2.17
1.8
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
103
774
1.34
2.16
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
309
2638
1.19
2.15
3.0
2.7
ml/min/173m2
65.8
64.2
0.28
139
1076
(3038515) Glucose [Moles/volume] in Venous blood
94
697
1.36
2.15
4.2
3.3
mmol/l
7.9
7.6
0.42
94
675
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
19
3.69
2.15
1.1
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
173
1394
1.25
2.15
6.0
5.4
%
0.8
0.9
0.96
165
1304
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
555
4957
1.14
2.14
1.3
1.2
u/ml
11.6
12.3
0.08
213
1905
(40768806) Pleura Pathology biopsy report
54
364
1.49
2.09
1.6
1.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
47
308
1.53
2.08
1.9
1.3
iu/ml
16.5
29.3
—
6
12
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
111
850
1.31
2.06
1.4
1.2
u/ml
74.5
25.9
—
9
46
(3042733) HLA Ab [Presence] in Serum
18
89
2.03
2.05
4.4
5.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
134
1054
1.28
2.04
1.7
1.6
titre
80.0
394.7
—
7
49
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
93
695
1.35
2.04
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
93
695
1.35
2.04
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
165
1333
1.25
2.02
2.9
2.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
18
90
2.00
2.00
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
916
8459
1.11
2.00
1.6
1.6
mmol/l
1.4
1.4
0.50
769
7071
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
118
916
1.30
2.00
2.3
2.5
g/l
3.6
3.6
0.05
113
865
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
9
32
2.82
2.00
4.3
2.5
u/field
0.4
0.7
—
9
32
(3010421) pH of Blood
117
908
1.30
1.99
4.2
4.2
ph
7.4
7.4
0.07
96
761
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
28
163
1.72
1.98
1.1
1.1
iu/ml
9.6
12.3
—
7
49
(3024869) Neuronal Ab [Presence] in Serum
13
57
2.29
1.97
1.2
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
31
187
1.66
1.93
1.4
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
35
218
1.61
1.93
1.6
1.3
u/ml
1.9
1.1
0.30
16
105
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
33
2.73
1.93
1.6
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
94
711
1.33
1.92
2.7
3.1
nmol/l
0.8
0.8
0.19
71
540
(3023410) Appearance of Cerebral spinal fluid
46
306
1.51
1.92
1.5
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
241
2037
1.20
1.91
1.7
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
254
2158
1.19
1.90
9.1
7.0
mmol/l
24.9
24.6
0.68
235
2008
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
113
879
1.29
1.90
1.3
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
18
92
1.96
1.89
1.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
14
65
2.16
1.88
1.0
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
71
517
1.38
1.86
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
71
517
1.38
1.86
1.4
1.4
u/ml
93.5
119.4
1.70
18
103
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
29
174
1.67
1.86
2.3
2.2
ug/min
154.8
161.3
—
5
39
(3003181) Sodium [Moles/volume] in Urine
79
587
1.35
1.83
1.3
1.3
mmol/l
54.9
62.7
1.17
58
471
(3023323) Follitropin [Units/volume] in Serum or Plasma
129
1026
1.27
1.83
1.3
1.3
iu/l
35.3
31.8
0.50
108
885
(3018851) Theophylline [Moles/volume] in Serum or Plasma
10
40
2.50
1.83
1.3
1.4
umol/l
44.4
42.0
—
10
40
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
236
2000
1.19
1.83
3.9
3.6
mmol/l
2.4
1.8
1.75
172
1479
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
12
4.17
1.82
1.2
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
81
605
1.35
1.82
1.4
1.2
u/ml
40.9
39.6
—
10
67
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
53
2.27
1.80
1.2
1.7
ng/l
75.6
140.2
1.83
12
53
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3115
30509
1.11
1.80
5.0
4.7
mmol/l
6.1
6.0
5.30
2815
27664
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
47
320
1.47
1.78
1.3
1.5
%
29.2
30.6
0.09
28
197
(3051651) Icteric interference index of Serum or Plasma
31
192
1.62
1.77
3.8
3.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
87
660
1.33
1.77
1.3
1.3
u/l
10.0
10.5
0.13
67
541
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
361
4092
0.87
1.77
4.7
4.6
%
31.8
32.6
0.67
232
2731
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
35
224
1.57
1.76
1.2
1.3
mmol/l
13.8
12.2
0.41
14
68
(4015189)
17
88
1.94
1.74
3.3
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
100
776
1.30
1.74
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
54
380
1.43
1.74
1.6
1.4
e6/l
91061.4
92116.0
0.00
30
226
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
28
170
1.65
1.73
2.2
1.7
u/field
1.1
3.4
1.28
23
120
(3000570) Elastase.pancreatic [Mass/mass] in Stool
121
965
1.26
1.70
1.4
1.4
ug/g
262.3
277.0
0.35
80
567
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
47
0.00
1.70
0.0
1.2
—
90.6
—
0
32
(3000475) Leukocytes [#/volume] in Synovial fluid
102
798
1.29
1.68
1.7
1.6
e6/l
9481.7
13479.7
0.83
70
572
(3029937) Albumin [Presence] in Urine by Test strip
896
8335
1.10
1.67
4.7
4.2
estimate
0.0
0.0
1.28
301
2778
(40768441) Liver Pathology biopsy report
34
219
1.56
1.67
2.1
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
33
212
1.56
1.65
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
33
212
1.56
1.65
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
219
1864
1.19
1.64
1.2
1.2
iu/ml
124.1
147.7
0.39
62
681
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
100
783
1.28
1.64
1.5
1.2
u/ml
6.1
3.2
0.58
17
82
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
33
213
1.55
1.62
1.2
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
52
369
1.41
1.62
14.2
6.1
mmol/l
7.3
7.4
0.20
42
306
(3020891) Body temperature
164
1362
1.21
1.61
5.9
4.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
83
636
1.31
1.60
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
77
584
1.32
1.60
3.3
3.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
102
804
1.28
1.60
2.6
2.3
ug/min
63.0
108.5
1.42
70
487
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
33
215
1.54
1.56
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
33
215
1.54
1.56
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
33
215
1.54
1.56
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
93
727
1.29
1.56
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
49
347
1.42
1.55
1.2
1.4
mosm/kgh2o
284.0
277.6
1.93
42
260
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
103
818
1.27
1.53
1.5
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
170
1425
1.20
1.53
2.4
1.9
ug/l
2.6
2.3
0.13
150
1254
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
93
1.83
1.51
1.1
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
21
2.86
1.50
2.7
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
393
3520
1.13
1.50
2.2
2.2
ug/g
124.6
144.9
0.66
304
2773
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
100
794
1.27
1.49
1.5
1.3
u/ml
15.4
7.9
0.31
18
141
(40768793) Breast Pathology biopsy report
89
697
1.28
1.48
1.4
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
63
471
1.34
1.46
1.6
1.5
g/l
31.3
32.3
0.23
55
424
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
215
1850
1.17
1.45
12.7
9.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3196
31427
1.10
1.44
5.3
5.1
mmol/l
2.7
2.7
2.34
2923
28793
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
68
516
1.32
1.43
1.3
1.2
u/ml
366.9
279.8
1.06
38
315
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
38
261
1.46
1.43
1.9
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
114
925
1.24
1.43
1.9
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
98
782
1.26
1.42
1.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
76
587
1.30
1.42
1.4
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
239
2079
1.16
1.41
4.0
3.7
ph
7.4
7.4
0.18
46
248
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
118
1.70
1.41
1.2
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
148
1236
1.21
1.41
3.6
3.3
u/ml
1395.6
4176.8
0.58
131
1052
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
31
205
1.52
1.40
1.6
2.0
e6/l
664.0
689.7
0.08
11
86
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
271
1.44
1.39
2.3
2.1
u/field
1.7
2.0
0.26
18
103
(44816559) Phosphatidylethanol [Mass/volume] in Blood
67
511
1.32
1.38
1.1
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
30
198
1.52
1.37
1.3
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
46
331
1.39
1.36
1.7
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
50
365
1.37
1.36
1.4
1.3
u/ml
44.5
45.4
—
6
21
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
22
135
1.63
1.35
3.7
2.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
164
0.49
1.35
1.3
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
241
2107
1.15
1.34
4.0
3.7
kpa
5.2
5.2
0.53
229
1944
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
59
444
1.33
1.33
7.1
6.5
mg/l
12.4
12.0
0.27
53
415
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
40
282
1.42
1.33
1.4
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
52
384
1.36
1.33
1.4
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
49
359
1.37
1.32
1.6
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
104
845
1.24
1.31
4.8
4.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
62
472
1.32
1.30
1.4
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
67
516
1.30
1.30
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
139
1165
1.20
1.29
1.7
2.0
s
23.0
21.5
0.76
129
1032
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
18
2.78
1.28
1.0
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
33
226
1.46
1.28
1.5
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
48
2.09
1.27
1.0
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
15
84
1.79
1.27
1.4
1.3
ug/l
38.7
451.6
—
9
41
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
708
6610
1.09
1.23
3.0
3.1
ug/l
0.7
0.8
0.82
489
4496
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
101
825
1.23
1.23
1.4
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
170
1460
1.17
1.21
2.0
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
98
801
1.23
1.19
1.4
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
44
323
1.37
1.19
3.5
2.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
30
206
1.46
1.17
2.2
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
61
472
1.30
1.17
1.5
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
29
198
1.47
1.16
1.3
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
39
2.05
1.15
1.6
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
35
0.00
1.15
0.0
10.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
22
142
1.55
1.14
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
48
361
1.33
1.13
2.6
4.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
77
619
1.25
1.10
6.6
5.2
iu/ml
792.6
3024.6
0.43
17
89
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
7
31
2.26
1.10
1.4
1.2
u/l
20.3
24.6
—
7
20
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
179
1559
1.16
1.09
1.6
1.7
g/l
1.7
1.5
1.19
151
1338
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
31
218
1.43
1.09
1.3
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
41
303
1.36
1.08
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
23
152
1.52
1.08
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
55
425
1.30
1.08
1.6
1.4
e6/l
2241.6
2142.9
0.05
37
309
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
112
939
1.20
1.08
1.7
2.2
%
89.7
90.7
0.17
107
882
(3018133) Calcium [Moles/volume] in Urine
7
32
2.19
1.08
1.7
1.8
mmol/l
3.2
3.3
—
7
27
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
56
436
1.29
1.05
1.2
1.1
u/ml
0.3
1.6
2.54
23
179
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
74
597
1.24
1.04
1.4
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
9
46
1.96
1.03
2.3
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
70
562
1.25
1.03
2.6
3.4
%
1.4
1.4
0.02
53
435
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
138
1.52
1.02
1.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
716
6741
1.08
1.02
4.8
4.2
kg/l
1.0
1.0
0.13
92
1034
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
75
608
1.24
1.02
1.4
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
356
3252
1.10
1.02
1.7
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
230
1.39
1.01
1.3
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
49
377
1.30
1.01
1.1
1.1
u/ml
2.0
4.3
1.48
24
185
(3045683) HLA typing for celiac disease panel - Blood or Tissue
23
155
1.49
1.01
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
43
325
1.33
1.00
1.4
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
7
35
2.00
1.00
2.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
139
1.51
1.00
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
677
6367
1.08
1.00
1.3
1.2
u/ml
1.5
1.6
0.13
173
1668
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
107
1.59
0.99
2.4
2.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
18
115
1.57
0.99
1.7
1.6
umol/l
2.0
2.0
0.09
18
107
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
9
49
1.84
0.98
1.9
1.1
—
—
—
0
0
(3013512) EKG study
1016
9695
1.07
0.98
4.5
4.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
69
557
1.24
0.98
1.3
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
244
2189
1.12
0.98
2.8
3.1
e9/l
4.5
4.1
0.81
172
1679
(3019832) Treponema pallidum Ab [Presence] in Serum
157
1796
0.87
0.97
1.5
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
670
6305
1.08
0.97
1.9
1.8
nmol/l
1108.5
1173.5
0.95
490
4740
(3024928) Oxygen saturation in Venous blood
86
712
1.21
0.97
2.3
2.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3098
30556
1.07
0.95
4.7
4.5
mmol/l
1.4
1.5
8.29
2819
27988
(3003327) Ova and parasites identified in Stool by Light microscopy
108
916
1.18
0.95
1.6
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
66
535
1.24
0.92
1.5
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
24
167
1.44
0.91
2.7
3.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
47
366
1.29
0.91
1.1
1.1
u/ml
0.1
1.5
2.20
23
156
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
65
527
1.24
0.91
1.3
1.4
—
—
—
0
0
(44806420)
16
102
1.57
0.90
2.0
2.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
69
564
1.23
0.90
1.2
1.2
u/l
30.7
38.0
0.27
62
485
(3047007) Chlamydophila sp Ab [Presence] in Serum
49
386
1.27
0.88
1.3
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
381
0.73
0.87
1.5
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
79
657
1.21
0.87
1.3
1.2
—
7.0
—
0
8
(3022621) pH of Urine by Test strip
237
2140
1.11
0.87
3.8
3.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
77
639
1.21
0.87
1.4
1.2
u/ml
1.2
6.3
—
6
54
(3024263) Appearance of Synovial fluid
26
186
1.40
0.87
1.7
1.7
—
—
—
0
0
(1002224) Polysomnography panel
134
1168
1.15
0.86
1.1
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
28
204
1.38
0.85
1.1
1.2
mmol/l
44.6
34.5
0.84
20
174
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
45
1.78
0.84
3.5
4.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
63
515
1.23
0.83
1.5
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3117
30788
1.06
0.83
4.8
4.5
mmol/l
4.5
4.6
4.18
2869
28381
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
22
154
1.43
0.83
1.1
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
103
883
1.17
0.83
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
171
1.41
0.83
1.0
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
32
240
1.34
0.82
2.0
1.4
u/l
12.9
13.3
0.11
32
227
(3009466) Valproate [Moles/volume] in Serum or Plasma
55
445
1.24
0.80
4.8
5.2
umol/l
350.7
354.6
0.07
44
388
(3025315) Body weight
0
24
0.00
0.79
0.0
4.2
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
6
33
1.82
0.79
1.3
1.2
—
640.5
—
0
9
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
25
0.00
0.79
0.0
5.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
50
402
1.25
0.78
1.2
1.5
%
59.8
60.9
0.07
29
248
(4281824)
24
327
0.73
0.78
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
18
123
1.47
0.77
2.2
2.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
108
936
1.16
0.77
1.6
1.6
iu/ml
0.5
7.9
0.62
22
197
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
82
695
1.18
0.77
1.3
1.4
e6/l
21.9
26.7
0.15
62
536
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
82
695
1.18
0.77
1.3
1.4
e6/l
732.8
1283.7
0.45
65
564
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
24
174
1.38
0.76
1.1
1.1
u/l
1.0
1.1
—
9
94
(3000330) Specific gravity of Urine by Test strip
188
1692
1.12
0.76
4.2
3.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
34
261
1.31
0.76
1.0
1.1
u/ml
0.8
3.8
2.36
13
103
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1187
11460
1.05
0.76
5.0
5.1
ug/l
2.4
3.7
1.81
1050
10243
(3023383) Lactate [Moles/volume] in Pleural fluid
16
107
1.50
0.76
1.5
1.3
mmol/l
3.7
3.3
0.17
16
97
(3051101) Glucose [Moles/volume] in Cord blood
10
59
1.70
0.75
4.0
5.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
57
468
1.22
0.74
1.3
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
24
2.08
0.74
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
175
1.37
0.74
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
44
352
1.25
0.73
3.8
3.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
176
1.37
0.72
1.3
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
14
92
1.52
0.72
1.6
1.5
ug/l
8.7
8.7
0.00
14
92
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
954
9172
1.05
0.72
4.4
4.3
%
22.4
22.0
0.37
470
4588
(4211845)
23
168
1.37
0.71
2.7
3.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
57
1.58
0.71
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
103
897
1.15
0.71
1.2
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
26
1.92
0.70
1.2
1.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
26
1.92
0.70
3.2
2.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
26
1.92
0.70
6.4
5.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
26
1.92
0.70
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
41
1.71
0.70
1.1
1.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
25
186
1.35
0.70
2.4
2.7
%
37.0
39.9
—
8
66
(3014765) Yersinia sp identified in Stool by Organism specific culture
102
889
1.15
0.69
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
186
1684
1.11
0.69
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
143
0.63
0.69
1.1
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
168
1513
1.12
0.69
4.3
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
192
1742
1.11
0.69
2.4
2.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
233
2135
1.10
0.69
2.5
2.4
au/ml
36.1
22.9
—
9
100
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
21
152
1.38
0.69
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
21
152
1.38
0.69
1.2
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
27
353
0.76
0.68
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
27
353
0.76
0.68
1.4
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
160
1439
1.12
0.68
2.0
1.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
77
658
1.17
0.68
4.4
3.7
%
59.5
57.6
0.78
77
658
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
43
1.63
0.66
1.3
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
42
339
1.24
0.66
1.0
1.1
u/ml
0.1
2.0
—
7
83
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
17
120
1.42
0.64
1.1
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
211
1934
1.10
0.63
1.4
1.3
au/ml
74.5
50.9
—
8
86
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
41
332
1.24
0.63
1.3
1.2
u/l
66.3
59.6
0.27
29
222
(3006462) Nitrate [Presence] in Urine
21
155
1.36
0.63
2.7
3.7
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
19
257
0.74
0.62
1.1
1.0
ng/l
52.0
45.6
0.18
11
168
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
49
1.63
0.62
1.1
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2988
29554
1.05
0.61
4.2
4.1
mmol/l
1.3
1.3
3.20
2704
26854
(3051387) C reactive protein [Mass/volume] in Capillary blood
81
703
1.16
0.61
4.3
3.5
mg/l
21.7
28.2
1.10
59
437
(40761539) Cells [Type] in Urine sediment by Light microscopy
13
88
1.48
0.60
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
82
713
1.15
0.60
2.7
2.8
umol/l
32.3
36.3
0.83
69
597
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
84
732
1.15
0.60
2.8
3.3
u/ml
2150.6
702.0
0.53
77
669
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
21
0.00
0.60
0.0
1.4
—
23.0
—
0
9
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
51
426
1.20
0.60
1.2
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
105
1.43
0.60
1.3
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
19
255
0.74
0.59
1.1
1.0
ng/l
885.4
710.5
0.69
12
167
(3004775) Volume in Urine collected for unspecified duration
34
272
1.25
0.59
2.6
2.1
ml
552.9
627.2
0.54
24
174
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
146
1320
1.11
0.59
2.0
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
124
1112
1.12
0.58
1.7
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
37
300
1.24
0.58
1.4
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
37
300
1.24
0.58
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
37
300
1.24
0.58
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
28
354
0.79
0.58
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
28
354
0.79
0.58
1.5
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
38
310
1.23
0.57
1.4
1.3
e6/l
191331.6
89616.4
0.25
28
217
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
23
176
1.31
0.56
1.3
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
23
176
1.31
0.56
1.3
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
23
176
1.31
0.56
1.3
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
37
1.62
0.55
1.2
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
52
612
0.85
0.55
1.5
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
359
3388
1.07
0.54
1.7
1.8
%
1.5
1.5
0.01
324
2958
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
82
1.46
0.54
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
82
1.46
0.54
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
82
1.46
0.54
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
82
1.46
0.54
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
24
186
1.29
0.54
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
27
213
1.27
0.53
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
62
1.45
0.53
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
27
338
0.80
0.52
1.7
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
43
359
1.20
0.52
1.5
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
25
196
1.28
0.52
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
40
1.50
0.51
1.3
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
75
1.47
0.50
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
41
1.46
0.50
1.3
1.8
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
32
261
1.23
0.49
1.3
1.5
u/ml
24.8
20.9
—
6
56
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
32
261
1.23
0.49
1.4
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
48
408
1.18
0.49
1.2
1.3
nmol/l
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
29
234
1.24
0.49
1.0
1.0
u/ml
0.1
0.4
—
9
61
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
73
642
1.14
0.49
2.0
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
31
378
0.82
0.49
1.4
1.3
mmol/l
8.7
7.4
1.18
21
279
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
58
668
0.87
0.48
1.8
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
46
1.52
0.48
1.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
20
256
0.78
0.48
1.1
1.0
ng/l
353.2
322.9
0.17
12
172
(3005033) Fetal Nuchal fold Thickness US
23
289
0.79
0.47
1.5
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
24
299
0.80
0.46
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
288
0.80
0.46
1.3
1.2
—
—
—
0
0
(4034850)
95
1055
0.90
0.46
12.4
10.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
49
1.43
0.46
1.9
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
46
393
1.17
0.45
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
46
393
1.17
0.45
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
284
2681
1.06
0.45
4.8
4.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
44
375
1.18
0.45
1.0
1.1
u/ml
2.2
2.6
0.28
17
158
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
50
1.40
0.45
1.1
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
22
174
1.27
0.44
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
46
394
1.17
0.44
1.1
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
23
183
1.26
0.44
2.0
2.4
umol/l
88.7
25.6
—
5
17
(3047181) Lactate [Moles/volume] in Blood
98
1083
0.90
0.44
8.4
6.4
mmol/l
1.4
1.3
0.20
86
950
(3003694) ABO and Rh group [Type] in Blood
858
8335
1.04
0.43
1.4
1.4
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
11
78
1.41
0.43
2.0
1.9
mg/l
5.3
9.2
—
5
65
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
28
339
0.82
0.43
1.3
1.5
nmol/l
0.1
0.3
3.83
21
249
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
53
462
1.15
0.42
1.2
1.3
nmol/l
0.7
0.6
0.34
53
440
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
32
1.56
0.42
1.2
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
140
1.29
0.42
1.3
1.7
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
16
0.00
0.41
0.0
1.0
—
89.6
—
0
11
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
59
1.36
0.41
1.0
1.2
—
—
—
0
0
(3036603) Volume of Urine
25
204
1.23
0.40
1.6
1.4
ml
2176.0
1936.5
—
9
43
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
25
204
1.23
0.40
1.2
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
23
282
0.81
0.40
2.1
1.7
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
102
0.69
0.39
1.6
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
109
999
1.09
0.39
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
54
611
0.88
0.38
2.1
2.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
26
215
1.21
0.38
1.6
1.5
u/l
3.3
6.6
1.14
11
100
(21494755) Public health laboratory ask at order entry panel
215
2279
0.94
0.38
1.4
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
236
0.80
0.38
1.8
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
12
89
1.35
0.37
1.1
2.1
—
—
—
0
0
(4146454)
43
373
1.15
0.37
2.8
2.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
68
1.32
0.37
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
24
290
0.83
0.37
1.5
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
98
1.33
0.37
1.6
1.9
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
37
1.35
0.37
1.0
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
37
1.35
0.37
1.0
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
37
1.35
0.37
1.0
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
151
1408
1.08
0.37
1.3
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
72
1.39
0.36
1.1
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
25
207
1.21
0.36
1.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
36
417
0.86
0.35
1.5
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
79
0.63
0.35
1.4
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
17
135
1.26
0.35
1.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
181
1.22
0.34
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
48
424
1.13
0.34
2.3
2.2
mg/l
34.3
22.8
—
9
99
(3022689) Creatine [Moles/volume] in Urine
12
91
1.32
0.33
2.6
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
17
210
0.81
0.33
1.4
1.4
pmol/l
62.7
207.3
—
7
64
(4306422)
38
435
0.87
0.33
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
28
238
1.18
0.32
1.3
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
1.8
1.9
umol/l
16.4
18.2
—
6
47
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
201
1.20
0.32
1.5
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
110
1.27
0.31
2.1
1.9
ug/l
55.3
50.4
0.15
14
105
(3010370) Gastrin [Moles/volume] in Serum or Plasma
7
52
1.35
0.31
2.7
1.7
pmol/l
15.5
46.9
—
7
42
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
138
1.23
0.30
1.4
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
138
1.23
0.30
1.4
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
39
442
0.88
0.30
1.1
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
84
1.31
0.30
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
40
451
0.89
0.29
1.3
1.2
u/ml
1.6
3.8
1.53
15
145
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
28
324
0.86
0.29
1.0
1.1
%
89.6
95.2
0.67
28
304
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
89
823
1.08
0.29
1.7
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
185
1.19
0.29
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
185
1.19
0.29
1.1
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
55
497
1.11
0.28
1.1
1.1
iu/ml
127.7
1237.1
—
10
105
(21494890) Protein electrophoresis panel - 24 hour Urine
41
364
1.13
0.28
2.5
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
38
336
1.13
0.28
1.6
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
62
1.29
0.28
1.1
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
64
1.25
0.27
1.0
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
14
172
0.81
0.27
1.1
1.3
nmol/l
1.1
1.2
—
9
135
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
20
168
1.19
0.27
2.6
4.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
51
461
1.11
0.27
2.0
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
236
2261
1.05
0.27
1.2
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
122
1.23
0.27
1.1
1.1
u/ml
0.3
1.0
—
6
39
(3028300) Cannabinoids [Presence] in Urine
61
666
0.91
0.26
2.0
2.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
72
0.69
0.26
1.4
1.2
umol/l
14.8
16.7
—
5
64
(3011288) Drugs identified in Urine by Screen method
47
424
1.11
0.26
2.2
2.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
74
0.68
0.26
1.8
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
28
320
0.87
0.25
1.5
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
32
282
1.14
0.25
1.2
1.2
nmol/l
380.3
368.0
0.13
24
244
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
33
292
1.13
0.25
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
37
330
1.12
0.25
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
238
2287
1.04
0.24
2.0
2.2
nmol/l
10.9
12.6
2.62
210
1998
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
76
1.18
0.24
2.2
2.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
96
1.25
0.24
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
149
1567
0.95
0.24
1.5
1.5
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
19
161
1.18
0.24
1.3
1.2
u/l
182.5
368.5
1.30
19
151
(3027008) Opiates [Presence] in Urine
61
662
0.92
0.24
2.0
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
217
2086
1.04
0.23
1.2
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
51
467
1.09
0.22
1.2
1.3
nmol/l
0.1
0.4
—
5
27
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
20
172
1.16
0.22
1.3
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
14
116
1.21
0.22
1.1
1.0
u/ml
0.5
0.4
—
5
29
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
(3013862) HLA-DP [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
31
346
0.90
0.21
1.9
1.8
—
1193.3
—
0
12
(3014051) Protein [Presence] in Urine by Test strip
82
769
1.07
0.21
2.5
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
61
657
0.93
0.21
2.0
2.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
13
0.00
0.21
0.0
1.1
—
11.1
—
0
8
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
12.6
—
0
13
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
11
89
1.24
0.21
1.2
1.1
%
97.5
101.9
0.12
11
79
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
218
2102
1.04
0.20
1.9
1.9
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
32
287
1.12
0.20
1.0
1.1
u/ml
3.8
3.0
0.15
11
110
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
37
335
1.11
0.20
1.2
1.4
u/l
19.6
30.1
1.47
28
273
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
166
0.84
0.20
2.6
2.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
49
1.22
0.20
2.2
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
56
519
1.08
0.20
1.1
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
20
174
1.15
0.19
1.4
1.1
u/l
93.3
86.2
0.15
13
131
(3007566) Smooth muscle Ab [Titer] in Serum
89
841
1.06
0.19
1.3
1.2
titre
115.0
96.5
—
6
66
(3014891) Appearance of Pleural fluid
6
52
1.15
0.19
1.2
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
135
1292
1.05
0.18
4.4
4.0
mmol/l
25.1
24.8
0.70
126
1191
(3008898) HLA-B27 [Presence]
97
920
1.06
0.18
1.1
1.1
—
—
—
0
0
(4094501)
93
881
1.06
0.18
1.1
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
20
175
1.14
0.18
1.4
1.1
u/l
25.6
29.8
0.20
12
128
(3052592) Norovirus Ag [Presence] in Stool
7
58
1.21
0.18
1.6
1.4
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
12
142
0.84
0.17
1.3
1.7
nmol/l
3.1
7.4
0.65
12
118
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
71
1.13
0.16
1.4
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
71
1.13
0.16
2.4
2.2
—
—
—
0
0
(4198724)
8
72
1.11
0.16
1.5
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
43
399
1.08
0.16
1.3
1.2
—
—
—
0
0
(44813793)
21
187
1.12
0.15
1.1
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
58
545
1.07
0.15
1.4
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
76
0.79
0.15
9.3
7.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
15
130
1.15
0.15
1.5
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
421
4128
1.02
0.15
8.7
7.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
18
203
0.89
0.15
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
20
178
1.12
0.15
2.6
2.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
102
1.18
0.15
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
80
1.13
0.15
1.3
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
147
1419
1.04
0.15
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1055
10438
1.01
0.15
3.3
2.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
81
1.11
0.15
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
268
2747
0.97
0.15
3.8
3.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
88
0.80
0.14
10.1
7.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
112
1.16
0.14
1.6
1.5
—
1679021.4
—
0
7
(40765096) Chromosome analysis panel by Banding
13
112
1.16
0.14
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
66
696
0.95
0.14
1.3
1.3
miu/ml
148.3
213.2
1.06
22
307
(3035320) C reactive protein [Mass/volume] in Body fluid
25
227
1.10
0.14
3.0
2.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
92
881
1.05
0.14
1.3
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
80
838
0.95
0.14
1.4
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
41
439
0.93
0.13
1.3
1.2
u/ml
5.5
5.0
0.05
16
187
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
714
7053
1.02
0.13
1.8
1.7
pmol/l
438.0
30833045.8
5.46
592
5825
(3011648) Oxygen content in Venous blood
29
267
1.09
0.13
1.9
1.9
%
11.7
11.2
0.23
29
267
(3038177) Helicobacter pylori Ab [Presence] in Serum
48
452
1.06
0.13
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
62
652
0.95
0.12
2.0
1.9
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
123
1.14
0.12
3.6
2.6
umol/l
158.3
156.3
—
9
70
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
65
619
1.05
0.12
1.6
2.1
u/l
6184.3
3795.9
0.26
26
252
(3017354) Segmented neutrophils/100 leukocytes in Blood
37
346
1.07
0.12
2.6
3.4
%
56.2
57.0
0.06
24
218
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
124
1.13
0.11
2.6
2.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
86
1.16
0.11
1.1
1.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
21
192
1.09
0.10
1.9
1.6
u/l
5.3
7.4
1.27
16
167
(3016650) Hepatitis A virus Ab [Presence] in Serum
50
475
1.05
0.10
1.1
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
46
1.09
0.09
1.2
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
1.0
1.4
nmol/l
9.3
682058.1
—
5
39
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
116
1.12
0.09
2.5
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
223
1.08
0.09
1.1
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
97
1.13
0.09
2.1
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
93
902
1.03
0.09
1.8
1.8
—
—
—
0
0
(3019225) pH of Specimen
345
3403
1.02
0.08
4.8
4.5
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
6
56
1.07
0.08
1.0
1.4
%
83.7
106.2
—
6
51
(40768800) Prostate Pathology biopsy report
70
725
0.96
0.08
1.2
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
75
775
0.97
0.08
1.1
1.1
u/ml
2.5
5.3
0.96
12
87
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
117
1.11
0.08
3.0
1.9
ug/l
24.4
89.6
0.47
13
104
(4133840)
7
68
1.03
0.07
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
71
0.84
0.07
1.7
2.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
41
392
1.05
0.07
1.9
1.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
235
0.94
0.07
1.2
1.8
umol/l
4.4
8.7
0.96
17
158
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
107
1045
1.02
0.07
1.7
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
32
304
1.05
0.07
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
84
1.07
0.07
1.2
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
87
1.03
0.07
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
93
0.86
0.06
1.4
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
12
132
0.91
0.06
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
191
1881
1.02
0.06
1.9
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
100
0.90
0.06
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
105
0.86
0.06
1.0
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
23
217
1.06
0.06
1.1
1.3
—
68.8
—
0
17
(3001019) Free T4 and TSH panel - Serum or Plasma
130
1323
0.98
0.05
2.0
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
40
385
1.04
0.05
1.1
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
41
395
1.04
0.05
4.3
3.3
nmol/l
5.7
19.2
0.48
41
388
(1617658) Protocol used for examination of sentinel lymph nodes
26
247
1.05
0.05
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
42
405
1.04
0.05
1.5
1.4
—
—
—
0
0
(4024509)
34
326
1.04
0.05
1.5
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
240
2373
1.01
0.05
1.8
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
422
4253
0.99
0.05
1.4
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
30
288
1.04
0.04
2.4
1.9
—
1.5
—
0
12
(3028707) Methadone [Presence] in Urine by Screen method
30
288
1.04
0.04
2.6
2.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
42
407
1.03
0.04
1.5
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
30
312
0.96
0.04
4.6
3.1
mg/l
28.6
33.0
0.14
25
235
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
16
150
1.07
0.04
1.1
1.1
—
—
—
0
0
(44790048)
39
379
1.03
0.03
1.5
1.4
—
—
—
0
0
(44790049)
39
379
1.03
0.03
1.5
1.4
—
—
—
0
0
(44790047)
39
379
1.03
0.03
1.5
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
31
300
1.03
0.03
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
33
320
1.03
0.03
1.6
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
71
722
0.98
0.03
1.4
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
18
172
1.05
0.02
1.1
1.2
nmol/l
135.9
136.2
0.01
18
172
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
101
1021
0.99
0.02
1.8
1.7
mg/l
4.0
3.7
0.09
75
727
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
218
2167
1.01
0.02
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
40
408
0.98
0.01
1.6
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
52
512
1.02
0.01
2.1
1.9
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
21
203
1.03
0.01
1.0
1.1
nmol/l
0.2
7.7
—
6
46
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
15
144
1.04
0.00
13.7
11.6
mmol/l
0.7
0.6
0.25
15
130
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
35
344
1.02
0.00
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
404
1.02
0.00
1.6
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
112
0.98
0.00
1.2
1.1
miu/ml
2104.2
1607.2
0.57
11
112
(3051593) INR in Capillary blood by Coagulation assay
16
162
0.99
0.00
14.0
12.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
192
0.99
0.00
1.5
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
105
1.05
0.00
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
252
0.99
0.00
1.2
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
11
115
0.96
0.00
1.5
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
115
0.96
0.00
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
36
362
0.99
0.00
1.4
1.2
—
—
—
0
0
(4027681)
17
165
1.03
0.00
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
165
1.03
0.00
1.2
1.1
ratio
1.1
1.0
—
6
61
(3024522) Salmonella sp identified in Specimen by Organism specific culture
41
412
1.00
0.00
1.6
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
195
0.97
0.00
1.5
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
27
275
0.98
0.00
1.0
1.0
—
—
—
0
0
(4268621)
31
305
1.02
0.00
2.4
2.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
42
415
1.01
0.00
1.5
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
115
1148
1.00
0.00
3.0
3.1
g/l
0.5
0.3
0.65
55
453
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
111
0.99
0.00
1.2
1.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
12
121
0.99
0.00
2.3
2.4
e6/l
1283.8
702.6
—
6
90
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
129
1.01
0.00
1.1
1.3
—
—
—
0
0
(44806118)
38
379
1.00
0.00
1.5
1.4
—
—
—
0
0
(3039000) Anion gap in Blood
78
779
1.00
0.00
8.7
7.3
mmol/l
10.5
11.2
1.54
70
695
(3018572) Chloride [Moles/volume] in Blood
78
779
1.00
0.00
8.7
7.3
mmol/l
105.3
105.1
0.08
70
695
(3033799) Differential panel - Peritoneal fluid
10
104
0.96
0.00
2.2
2.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
17
166
1.02
0.00
2.0
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
21
207
1.01
0.00
2.1
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
24
243
0.99
0.00
1.3
1.4
promille
1.2
1.2
0.04
18
183
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
133
0.98
0.00
1.2
1.1
iu/ml
214.1
206.5
0.03
13
133
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
92
0.98
0.00
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
92
0.98
0.00
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
92
0.98
0.00
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
100
1.00
0.00
1.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
98
0.92
0.00
1.2
1.3
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
2984.0
—
0
5
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
1285.6
—
0
7
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
75
0.93
0.00
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
91
0.99
0.00
1.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
19.8
—
0
6
(3020650) Glucose [Presence] in Urine
8
82
0.98
0.00
1.3
1.5
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
83
0.96
0.00
1.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
67
0.90
0.00
1.0
1.8
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.2
—
0
6
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
80
1.00
0.00
1.1
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
49
490
1.00
0.00
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
93
0.97
0.00
1.7
1.7
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
93
0.97
0.00
1.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
129.9
—
0
5
(3040893) Potassium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
4.7
—
0
7
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
174.4
—
0
5
(3034426) Prothrombin time (PT)
10
100
1.00
0.00
1.2
1.3
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_SALIVARY and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_SALIVARY 1.266 [1.15, 1.4] < 0.001
Birth year 0.996 [0.99, 1.0] 0.298

During the follow-up period (1.1.1998 — 31.12.2019), 1813 out of 9078 females with CD2_BENIGN_SALIVARY died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_SALIVARY 1.404 [1.27, 1.55] < 0.001
Birth year 0.989 [0.98, 1.0] 0.016

During the follow-up period (1.1.1998 — 31.12.2019), 2119 out of 8404 males with CD2_BENIGN_SALIVARY died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_SALIVARY.

N-year risk Females Males
1 0.116% 0.207%
5 0.742% 1.619%
10 1.878% 4.099%
15 3.653% 7.984%
20 6.59% 13.355%

Relationships between endpoints

Index endpoint: CD2_BENIGN_SALIVARY – Benign neoplasm of major salivary glands

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data